NEONC TECHNOLOGIES HOLDINGS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $582.22 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $972.77K.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$390.55K, a 162.16% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $2.77M, a 229.79% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$1.70M.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $1.12M, a 37.89% decline from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $1.80M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $972.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $582.22K 10-Q · filed 2026-08-10 | $3.36M derived: sum of 3 quarters · filed 2026-08-10 | $1.65M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$390.55K 10-Q · filed 2026-05-15 | $2.38M derived: sum of 2 quarters · filed 2026-05-15 | $681.26K derived: sum of 3 quarters · filed 2026-05-15 | $98.33K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.07M derived: sum of 2 quarters · filed 2026-03-31 | $488.88K derived: sum of 3 quarters · filed 2026-03-31 | $1.12M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.29M derived: sum of 2 quarters · filed 2025-11-14 | -$1.66M 10-Q · filed 2025-11-14 | -$816.30K derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-06-30 | -$582.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $45.35K 10-Q · filed 2025-08-18 | $886.77K derived: sum of 3 quarters · filed 2026-03-31 | $292.66K derived: sum of 4 quarters · filed 2026-03-31 |
| 2025-03-31 | $628.28K 10-Q · filed 2025-05-09 | $1.47M derived: sum of 2 quarters · filed 2026-03-31 | $875.59K derived: sum of 3 quarters · filed 2026-03-31 | $1.43M derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-12-31 | $841.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $247.31K derived: sum of 2 quarters · filed 2026-03-31 | $797.52K derived: sum of 3 quarters · filed 2026-03-31 | $1.80M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$594.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$43.90K derived: sum of 2 quarters · filed 2025-11-14 | $957.16K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $550.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $1.55M 10-Q · filed 2025-08-18 | ||
| 2024-03-31 | $1.00M 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |